NICOLE THOMPSON: Open Payments
NPI 1396281291 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 40 payments from 9 companies in 2025. Trend: 2023 $145 · 2024 $328 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $245 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| Lilly USA, LLC | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| ABBVIE INC. | 2 | $55 |
| PFIZER INC. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
Products named: CAPLYTA, AIRSUPRA, MOUNJARO, FANAPT, REXULTI, VOQUEZNA, EMBLAVEO, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
